Response to: ‘Expanding the evidence base for Uromonitor®: updated pooled performance across eight cohorts’

Documents similaires

• Expanding the evidence base for Uromonitor®: updated pooled performance across eight cohorts
  par: Matthias May, et autres
  Publié: (2025)
• Response to: “Caution in interpreting the diagnostic superiority of digital Uromonitor in NMIBC surveillance”
  par: José Rubio‐Briones
  Publié: (2026)
• Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial
  par: Ingmar Wolff, et autres
  Publié: (2024)
• Caution in interpreting the diagnostic superiority of digital Uromonitor in NMIBC surveillance
  par: Jinhu Ma, et autres
  Publié: (2026)
• External validation of the Uromonitor®‐version 2 urine test as a biomarker for optimisation of non‐muscle‐invasive bladder cancer management
  par: José Rubio‐Briones, et autres
  Publié: (2025)